These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24575541)

  • 1. In germ cell cancer, are we at the end of the chemotherapy era? Maybe--and we are certainly at the end of the RCT era.
    Maroni P
    Oncology (Williston Park); 2013 Nov; 27(11):1136, 1143. PubMed ID: 24575541
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy in nonseminomatous germ cell cancer.
    Kollmannsberger C; Beyer J; Bokemeyer C
    BJU Int; 2009 Nov; 104(9 Pt B):1398-403. PubMed ID: 19840020
    [No Abstract]   [Full Text] [Related]  

  • 3. In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demise.
    Raghavan D
    Oncology (Williston Park); 2013 Nov; 27(11):1137, 1143. PubMed ID: 24575542
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of poor-prognosis or relapsed germ-cell cancer.
    Daugaard G
    BJU Int; 2009 Nov; 104(9 Pt B):1392-7. PubMed ID: 19840019
    [No Abstract]   [Full Text] [Related]  

  • 5. Curing metastatic cancer: lessons from testicular germ-cell tumours.
    Masters JR; Köberle B
    Nat Rev Cancer; 2003 Jul; 3(7):517-25. PubMed ID: 12835671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of iproplatin in refractory germ cell tumors: a Southeastern Cancer Study Group trial.
    Drasga RE; Williams SD; Einhorn LH; Birch R
    Cancer Treat Rep; 1987 Sep; 71(9):863-4. PubMed ID: 3040247
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II trial of mitoxantrone in refractory germ cell tumors: a trial of the Southeastern Cancer Study Group.
    Williams SD; Birch R; Gams R; Irwin L
    Cancer Treat Rep; 1985 Dec; 69(12):1455-6. PubMed ID: 3000593
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy for good-risk germ cell tumors: current concepts and controversies.
    Vaughn DJ
    Urol Clin North Am; 2007 May; 34(2):171-7; abstract viii-ix. PubMed ID: 17484922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the Australasian Germ Cell Trial Group: the management of advanced testis cancer.
    Raghavan D; Levi J; Thomson D; Harvey V
    Prog Clin Biol Res; 1990; 350():319-29. PubMed ID: 1696742
    [No Abstract]   [Full Text] [Related]  

  • 10. [The role of chemotherapy in the treatment of testicular cancer with the exception of seminomas].
    Kenis Y; Piccart M; Beer M
    Rev Med Brux; 1983 Apr; 4(4):219-23. PubMed ID: 6192477
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapeutic treatment regimens for germinal testicular tumors].
    Hofmann W; Langkopf B; Heinrichs HJ; Rebmann U
    Z Urol Nephrol; 1983 Nov; 76(11):741-50. PubMed ID: 6320553
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose chemotherapy for male germ cell tumor.
    Hara I; Miyake H; Yamada Y; Takenaka A; Fujisawa M
    Int J Urol; 2006 Aug; 13(8):1037-44. PubMed ID: 16903926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and chemotherapy of a human germ-cell tumour line (GCT 27).
    Schlappack OK; Bush C; Delic JI; Steel GG
    Strahlenther Onkol; 1989 Jul; 165(7):541. PubMed ID: 2473535
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy for clinical stage I nonseminomatous germ cell tumours.
    Vaughn DJ
    BJU Int; 2009 Nov; 104(9 Pt B):1381-6. PubMed ID: 19840017
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of malignant testicular tumors].
    Weissbach L; Jaeger N; Hartlapp JH; Boedefeld EA; Vahlensieck W
    Urologe A; 1983 Sep; 22 Suppl():310-21. PubMed ID: 6314621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
    Stoter G; Denis L
    Acta Urol Belg; 1985; 53(2):428-40. PubMed ID: 2409785
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
    Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
    Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of post-chemotherapy surgery in germ cell tumors.
    Sim HG; Lange PH; Lin DW
    Urol Clin North Am; 2007 May; 34(2):199-217; abstract ix. PubMed ID: 17484925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of late cardiovascular toxicity from cancer chemotherapy.
    Steingart R
    J Clin Oncol; 2005 Dec; 23(36):9051-2. PubMed ID: 16301591
    [No Abstract]   [Full Text] [Related]  

  • 20. The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?
    Necchi A; Nicolai N; Giannatempo P; Raggi D; Miceli R; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2016 Feb; 14(1):1-4. PubMed ID: 26329776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.